Loop Capital Maintains Buy on Ardent Health Partners, Raises Price Target to $21
Portfolio Pulse from Benzinga Newsdesk
Loop Capital analyst Timothy Greaves maintains a Buy rating on Ardent Health Partners (NYSE:ARDT) and raises the price target from $18 to $21.
August 16, 2024 | 12:17 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Loop Capital analyst Timothy Greaves maintains a Buy rating on Ardent Health Partners and raises the price target from $18 to $21.
The Buy rating and increased price target from a reputable analyst can boost investor confidence and potentially drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100